2014-06-02 - Female
900100274
| Adverse reaction report number | 900100274 |
| Latest AER version number | 0 |
| Market authorization holder AER number | CA201402560 |
| Initial received date | 2014-06-02 |
| Latest received date | 2014-06-02 |
| Age | N/A |
| Gender | Female |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Pharmacist |
| Source of report | MAH |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | Attention deficit/hyperactivity disorder |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Drug ineffective | |
| Fatigue | |